Cultivation
What APAC Producers Get Wrong About EU-GMP
Written by Dr Nickel Dittrich, Managing Director, GMPion When Asia-Pacific producers talk about Europe, the conversation usually starts in the grow room.
GACP
8stories
21 Septlast updated
More in GACP
- Investment & Finance
French Excellence at the Heart of a High-Capacity EU-GMP Site
PGP Farmer closes a €3m funding round to become a leading player in EU-GMP medical cannabis production in Europe French biotech company PGP Farmer unveils the closing of a €3 million funding round with private investors.
- UK & Europe
No EU Monograph for Cannabis Flowers Over ‘Lack of Evidence’ as New GACP Rules Loom
The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) published a draft opinion on July 09, open for consultation between 1 August and 31 October 2025, which concludes that no EU monograph can currently be created for Cannabis sativa L., flos.
- Medical
Could Colombian Cannabis Become the Next Big Thing in Europe?
Colombia’s cannabis market has had a tumultuous journey to date, with just a fraction of its potential as a global cultivation powerhouse being fulfilled.
